Cornerstone Therapeutics has launched Bethkis tobramycin inhalation solution for the treatment of cystic fibrosis patients with P. aeruginosa infections in the US, the company said. According to Cornerstone, one dose of Bethkis contains 300 mg of tobramycin in 4 mls of solution and can be delivered in about 15 minutes using a PARI LC Plus nebulizer. The company … [Read more...] about Cornerstone launches Bethkis tobramycin inhalation solution
News
Inhalation Asia 2013 presentations now available online
In accordance with their promise to provide open access to meeting materials, the organizers of Inhalation Asia 2013 have made all of the presentations from the meeting available on the meeting's website. The presentations include research that is applicable globally as well as papers specific to Asia such as "Inhalation delivery of traditional Chinese medicine … [Read more...] about Inhalation Asia 2013 presentations now available online
Aradigm appoints Juergen Froehlich new chief medical officer
Aradigm has announced the appointment of Juergen Froehlich as Chief Medical Officer. Froehlich is formerly Head of Regulatory Affairs at Vertex Pharmaceuticals where he was responsible for regulatory submissions for Kalydeco. Both of Aradigm's inhaled ciprofloxacin formulations, Pulmaquin and Lipoquin, were licensed by Grifols earlier this year. Aradigm … [Read more...] about Aradigm appoints Juergen Froehlich new chief medical officer
Particle Sciences to develop intranasal progesterone for BHR Pharma
Particle Sciences has announced that it has been awarded a contract for development of an intranasal progesterone formulation for the treatment of traumatic brain injury by BHR Pharma, a subsidiary of Besins Healthcare. Besins announced in April 2013 that it had licensed the Muco (μco) intranasal system from Shin Nippon Biomedical Laboratories (SNBL) for nasal … [Read more...] about Particle Sciences to develop intranasal progesterone for BHR Pharma
Timer Designs launches Advair/Seretide Compliance Cradle
Dutch pharmaceutical compliance specialist Timer Designs has announced the launch of the Compliance Cradle for Advair/Seretide Diskus inhalers. The device monitors the presence of the Diskus and alerts patients to take a dose of the medication if the inhaler remains situated in the cradle past the scheduled dosing time. The Compliance Cradle utilizes an optical … [Read more...] about Timer Designs launches Advair/Seretide Compliance Cradle
Relvar Ellipta approved in EU
GSK and Theravance have announced that the European Commission has approved Relvar Ellipta fluticasone furoate/vilanterol (FF/VI) DPI for the treatment of asthma for patients whose disease is not adequately controlled by ICS plus an as-needed SABA and for COPD where patients do not have adequate control with regular bronchodilator use. Relvar has been approved in … [Read more...] about Relvar Ellipta approved in EU
Intertek announces new comprehensive OINDP services
Intertek, which recently acquired Melbourn Scientific, has announced the launch of development, formulation and characterization service for both large and small molecule inhaled and nasal drug products. The acquisition of Melbourn Scientific was announced in July 2013. The company's OINDP services include formulation, analytical method development and validation, … [Read more...] about Intertek announces new comprehensive OINDP services
Civitas gets new patent for inhaled L-dopa
The United States Patent and Trademark Office (USPTO) has issued Civitas Therapeutics US Patent No. 8,545,878, with an expiration date of November 16, 2032, for a patent titled “Capsules containing high doses of levodopa for pulmonary use.” Civitas says that it now has more than 115 patents related to its CVT-301 inhaled L-dopa for the treatment of Parkinson's … [Read more...] about Civitas gets new patent for inhaled L-dopa
Bend Research adds spray drying capacity
Bend Research has announced a $20+ million expansion of its commercial spray drying capacity, including a new commercial manufacturing facility with two PSD spray dryer process trains. The company expects completion and validation of the new facility by mid-2015. By spring of 2014, the company said that it will also have added another high-capacity PSD spray dryer … [Read more...] about Bend Research adds spray drying capacity
Acorda submits regulatory application for diazepam nasal spray
In a November 5, 2013 interview on CNBC, Acorda CEO Ron Cohen announced that the company has filed a regulatory application to the FDA for its diazepam nasal spray for the treatment of epilepsy. Acorda has announced previously that it planned to submit a 505(b)(2) application for the product. Cohen said that if the drug is approved, the drug could be marketed as … [Read more...] about Acorda submits regulatory application for diazepam nasal spray